National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009

Drug and Alcohol Dependence

Volumn 131, Issue 3, 2013, Pages 263-270

  Calcaterra, Susan ^a,b   Glanz, Jason ^c,d   Binswanger, Ingrid A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c Kaiser Permanente Colorado   (United States)

^d Global Health and Health Disparities   (United States)

Author keywords

Heroin; Mortality; Overdose; Pharmaceutical opioids; Poisoning; Stimulants

Indexed keywords

2 PROPANOL; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COCAINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FENTANYL; HYPNOTIC SEDATIVE AGENT; METHADONE; METHAMPHETAMINE; METHANOL; MONOAMINE OXIDASE INHIBITOR; MORPHINE; OPIATE; PETHIDINE; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; DEATH CERTIFICATE; DRUG FATALITY; DRUG OVERDOSE; FEMALE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNITED STATES;

HEROIN; MORTALITY; OVERDOSE; PHARMACEUTICAL OPIOIDS; POISONING; STIMULANTS;

ADOLESCENT; ADULT; CAUSE OF DEATH; DATABASES, FACTUAL; DRUG OVERDOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84881261103     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.11.018     Document Type: Article

References (58)

1. Albert S., Brason F.W., Sanford C.K., Dasgupta N., Graham J., Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011, 12:S77-S85.
2. Andrews J.Y., Kinner S.A. Understanding drug-related mortality in released prisoners: a review of national coronial records. BMC Public Health 2012, 12:270.
3. Call K.T., McAlpine D.D., Johnson P.J., Beebe T.J., McRae J.A., Song Y. Barriers to care among American Indians in public health care programs. Med. Care 2006, 44:595-600.
4. Centers for Disease Control and Prevention, 2004. Unintentional and undetermined poisoning deaths-11 states, 1990-2001. 53, 233-238.
5. Centers for Disease Control and Prevention, 2012. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. 514 MMWR 61,101-105.
6. Centers for Disease Control and Prevention, 2011. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR 60, 1487-1492.
7. Centers for Disease Control and Prevention, 2012. CDC WONDER Database. (Accessed on June, 2012). http://wonder.cdc.gov/mcd.html.
8. Cornish R., Macleod J., Strang J., Vickerman P., Hickman M. Risk of death during and after opiate substitution treatment in primary care: a prospective observational study in UK General Practice Research Database. BMJ 2010, 341:5475.
9. Davis W.R., Johnson B.D. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008, 92:267-276.
10. Federation of State Medical Boards of the US, 1998. Model Guidelines for the Use of Controlled Substance for the Treatment of Pain: A Policy Document of the Federation of State Medical Boards of the United States, Inc. Dallas, TX.
11. Firestone M., Fischer B. A qualitative exploration of prescription opioid injection among street-based drug users in Toronto; behaviours, preferences and drug availability. Harm Reduct. J. 2008, 5:30.
12. Gone J., Trimble J. American Indian and Alaska Native mental health: diverse perspectives on enduring disparities. Annu. Rev. Clin. Psychol. 2012, 8:131-160.
13. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
14. Grau L.E., Dasgupta N., Harvey A.P., Irwin K., Givens A., Kinzly M.L., Heimer R. Illicit use of opioids: is OxyContin a "gateway drug"?. Am. J. Addict. 2007, 16:166-173.
15. Gupta A., Patton C., Diskina D., Cheatle M. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Pain Physician 2011, 14:383-389.
16. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
17. Harlow K.C. Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976-87. Public Health Rep. 1990, 105:455-462.
18. Havens J.R., Walker R., Leukefeld C.G. Benzodiazepine use among rural prescription opioid users in a community-based study. J. Addict. Med. 2010, 4:137-139.
19. Hetch M.L., Marsiglia F.F., Elek E., Wagstaff D.A., Kulis S., Dustman P., Miller-Day M. Culturally grounded substance use prevention: an evaluation of the keepin' it REAL curriculum. Prev. Sci. 2003, 4:233-248.
20. Inciardi J.A., Surratt H.L., Cicero T.J., Beard R.A. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009, 10:537-548.
21. Jones A.W., Kugelberg F.C., Holgren A., Ahlner J. Drug poisoning deaths in Sweden show a predominance of ethanol in mono-intoxications, adverse drug-alcohol interactions and poly-drug abuse. Forensic Sci. Int. 2011, 206:43-51.
22. Jones J.D., Mogali S., Comer S.D. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012, 125:8-18.
23. Katz R. Addressing the health care needs of American Indians and Alaska Natives. Am. J. Public Health 2004, 94:13-14.
24. Lankenau S.E., Teti M., Silva K., Jackson Bloom J., Harocopos A., Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 2012, 23:37-44.
25. Martyres R., Cloade D., Burns J.M. Seeking drugs or seeking help? Escalating "doctor shopping" by heroin users before fatal overdose. Med. J. Aust. 2004, 180:211-214.
26. McCabe S.E., Cranford J.A., West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict. Behav. 2008, 33:1297-1305.
27. Mittleman R.E., Wetli C.V. Death caused by recreational cocaine use: an update. JAMA 1984, 12:1889-1893.
28. Moulton P.L., Miller M.E., Offutt S.M., Gibbens B.P. Identifying rural health care needs using community conversations. J. Rural Health 2007, 23:92-96.
29. National Drug Intelligence Center, 2007. Methadone diversion, abuse, and misuse: Deaths increasing at alarming rate. Drug Enforcement Administration, U.S. Department of Justice. Product No. 2007-Q0317-001. Johnstown, PA: November 2007. (Accessed on January, 2012). http://www.justice.gov/ndic/pubs25/25930/25930p.pdf.
30. Nielsen S., Bruno R., Lintzeris N., Fischer J., Carruthers S., Stoové M. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?. Drug Alcohol Rev. 2011, 30:291-299.
31. Office of National Drug Control Policy. 2011. Epidemic: Responding to America's Prescription Drug Abuse Crisis. (Accessed on January, 2012). http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf.
32. Paulozzi L.J. Drug-induced deaths-United States, 2003-2007. MMWR Surveill. Summ. 2011, 60(Suppl.):60-61.
33. Paulozzi L.J., Budnitz D.S., Yongli X. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 2006, 15:618-627.
34. Paulozzi L.J., Kilbourne E.M., Nolte K.B., Desai H.A., Landen M.G., Harvey W., Loring L.D. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012, 13:87-95.
35. Phillips D.M. JCAHO pain management standards are unveiled Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000, 284:428-429.
36. Rigg K.K., Kurtz S.P., Surratt H.L. Patterns of prescription medication diversion among drug dealers. Drugs 2012, 19:144-155.
37. Substance Abuse and Mental Health Services Administration, 2005. The NSDUH Report: Methamphetamine Use, Abuse, and Dependence: 2002, 2003, and 2004. Office of Applied Studies, Rockville, MD. http://www.samhsa.gov/data/2k5/meth/meth.htm. (Accessed on January, 2012).
38. Substance Abuse and Mental Health Services Administration, 2005. Results from the 2004 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-28, DHHS Publication No. SMA 05-4062). Rockville, MD. http://www.oas.samhsa.gov/NSDUH/2k4NSDUH/2k4results/2k4results.htm#ch7. (Accessed on August, 2012).
39. Substance Abuse and Mental Health Services Administration, 2007. Methadone Mortality-A Reassessment. Washington DC. Substance Abuse Treatment. US Department of Health and Human Services. http://www.atforum.com/pdf/Methadone_Draft_Report_101807_Brief-w-attch.pdf. (Accessed on March, 2012).
40. Substance Abuse and Mental Health Services Administration, 2007. The NSDUH Report: Methamphetamine Use. Office of Applied Studies, Rockville, MD. http://www.samhsa.gov/data/2k7/meth/meth.pdf. (Accessed January, 2012).
41. Substance Abuse and Mental Health Services Administration, 2009. Treatment Episode Data Set (TEDS).
42. Substance Abuse and Mental Health Services Administration, 2009. National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 11-4659, DAWN Series D-35. Rockville, MD. http://www.samhsa.gov/data/2k11/DAWN/2k9DAWNED/HTML/DAWN2k9ED.htm. (Accessed on January, 2012).
43. Substance Abuse and Mental Health Services Administration, 2010. The DAWN Report: Trends in Emergency Department Visits Involving Non-medical Use of Narcotic Pain Relievers. Office of Applied Studies, Rockville, MD. http://oas.samhsa.gov/2k10/dawn016/opioided.htm. (Accessed on January, 2012).
44. Substance Abuse and Mental Health Services Administration, 2011. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: http://www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.pdf. (Accessed on January, 2012).
45. Scanlon M.N., Chugh U. Exploring physicians' comfort level with opioids for chronic non cancer pain. Pain Res. Manag. 2004, 9:195-201.
46. Siegal H.A., Carlson R.G., Wang J., Falck R.S., Stephens R.C., Nelson E.D. Injection drug users in the Midwest: an epidemiologic comparison of drug use patterns in four Ohio cities. J. Psychoactive Drugs 1994, 26:265-275.
47. Straand J., Rokstad K.S. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the Møre and Romsdal Prescription Study. Fam. Pract. 1999, 16:380-388.
48. Tardiff K., Marzuk P.M., Leon A.C., Portera L., Hartwell N., Hirsch C.S., Stajic M. Accidental fatal drug overdoses in New York City: 1990-1992. Am. J. Drug Alcohol Abuse 1996, 22:135-146.
49. Unger J.B. The most critical unresolved issues associated with race, ethnicity, culture, and substance use. Subst. Use Misuse 2012, 47:390-395.
50. US Department of Justice, 2011. Automation of Reports and Consolidated Orders System (ARCOS). Springfield, VA: US Department of Justice, Drug Enforcement Administration. (Accessed on March, 2012). http://www.deadiversion.usdoj.gov/arcos/index.html.
51. US Government Accountability Office, 2009. Methadone-associated Overdose Deaths: Factors Contributing to Increased Deaths and Efforts to Prevent Them. GAO-09-34126 Mar 2009. (Accessed on March, 2012). http://www.gao.gov/products/GAO-09-341.
52. Verstraete A.G. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 2004, 26:200-205.
53. Warner M., Chen L.H., Makuc D.M. Increase in Fatal Poisonings Involving Opioid Analgesics in the United States, 1999-2006. NCHS data brief no 22 2009, National Center for Health Statistics, Hyattsville, MD.
54. Webster L., Cochella S., Dasgupta N., Fakata K.L., Fine P.G., Fishman S.M., Grey T., Johnson E.M., Lee L.K., Passik S.D., Peppin J., Porucznik C.A., Ray A., Schnol S.H., Stieg R.L., Wakeland W. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med. 2011, 12:S26-S35.
55. World Health Organization, 2012. (Accessed on June, 2012). http://www.who.int/healthinfo/statistics/mortdata/en/index.html.
56. Wilkins C., Sweetsur P., Griffiths R. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009. Drug Alcohol Rev. 2011, 30:255-263.
57. Wolf B., Grohmann R., Biber D., Brenner P.M., Ruther E. Benzodiazepine abuse and dependence in psychiatric inpatients. Pharmacopsychiatry 1989, 22:54-60.
58. Yanni L.M., McKinney-Ketchum J.L., Harrington S.B., Huynh C., Amin, Bs S., Matsuyama R., Coyne P., Johnson B.A., Fagan M., Garufi-Clark L. Preparation, confidence, and attitudes about chronic non-cancer pain in graduate medical education. J. Grad. Med. Educ. 2010, 2:260-268.